Organon & Co.

NYSE:OGN Stock Report

Market Cap: US$4.8b

Organon Future Growth

Future criteria checks 2/6

Organon is forecast to grow earnings and revenue by 3.8% and 0.6% per annum respectively. EPS is expected to grow by 3.4% per annum. Return on equity is forecast to be 60.1% in 3 years.

Key information

3.8%

Earnings growth rate

3.4%

EPS growth rate

Pharmaceuticals earnings growth22.8%
Revenue growth rate0.6%
Future return on equity60.1%
Analyst coverage

Good

Last updated02 May 2024

Recent future growth updates

Recent updates

Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Apr 21
Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Organon Stock Is Still Worth A Look

Feb 24

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Feb 19
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last

Feb 16

Organon: What I'm Looking For In This 8% Yield In 2024

Jan 03

High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued

Dec 19

Organon: It's Darkest Before The Dawn

Nov 30

Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace

Nov 07

Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Nov 05
Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Organon: The Federal Reserve Black Swan (Rating Upgrade)

Oct 04

6% Yield And Significantly Undervalued: A Closer Look At Organon

Sep 10

Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk

Aug 10

Organon & Co.: A Tough Spot To Be In Right Now

Jul 16

Organon goes ex-dividend tomorrow

Feb 23

Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 19
Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Is There Anything Organic Or Interesting About Organon?

Feb 07

Organon goes ex-dividend tomorrow

Nov 09

Organon's (NYSE:OGN) Dividend Will Be $0.28

Nov 08
Organon's (NYSE:OGN) Dividend Will Be $0.28

Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)

Nov 05
Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)

Organon: Thoughts Ahead Of Q3 Earnings

Oct 31

Organon: What Is The Recipe?

Aug 31

Oragenics announces early toxicology data for intranasal COVID-19 vaccine

Aug 24

Organon, Samsung Bioepis Humira biosimilar Hadlima high concentration dosage gets FDA nod

Aug 17

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Aug 07
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Organon Q2 2022 Earnings Preview

Aug 03

Organon in pact with Cirqle Biomedical for contraceptive candidate

Jul 28

Organon: Some Uncomfortable Questions Ahead Of Q2 Earnings

Jul 18

Organon Vs. Viatris: Who Is The Clear Winner?

Jun 20

Organon: Maximum Optimism

Apr 28

Viatris Vs. Organon: Surprisingly Undervalued, But Which Is The Better Buy?

Feb 19

Earnings and Revenue Growth Forecasts

NYSE:OGN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,5411,0821,1291,1696
12/31/20256,4709811,0471,1257
12/31/20246,3907888411,1757
12/31/20236,2631,023538799N/A
9/30/20236,150585424669N/A
6/30/20236,168754320725N/A
3/31/20236,145746431849N/A
12/31/20226,174917431858N/A
9/30/20226,2921,011138638N/A
6/30/20226,3551,107343689N/A
3/31/20226,3651,3045641,077N/A
12/31/20216,3041,3511,9702,458N/A
9/30/20216,3141,5252,3702,841N/A
6/30/20216,3271,7622,3042,761N/A
3/31/20216,2581,9172,7723,025N/A
12/31/20206,5322,2561,9322,187N/A
12/31/20197,7773,3062,6752,767N/A
12/31/20189,7772,1533,5863,687N/A
12/31/201710,5001,8013,3333,419N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OGN's forecast earnings growth (3.8% per year) is above the savings rate (2.4%).

Earnings vs Market: OGN's earnings (3.8% per year) are forecast to grow slower than the US market (14% per year).

High Growth Earnings: OGN's earnings are forecast to grow, but not significantly.

Revenue vs Market: OGN's revenue (0.6% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: OGN's revenue (0.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: OGN's Return on Equity is forecast to be very high in 3 years time (60.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.